Using monoclonal antibody cocktails to fight RSV Researchers at two Chinese universities have shown that combination antibody therapies could prevent respiratory infections.

Monoclonal antibody cocktails show promise in combating RSV, reducing viral titers in studies. A new frontier in respiratory infection prevention.
#RSV #AntibodyTherapy

Read my full article below:

www.bioxconomy.com/modalities/s...

New hope for toughest myeloma through off-the-shelf immunotherapy – BioNews Central An off-the-shelf dual-antibody therapy can produce deep and durable responses in extramedullary multiple myeloma, one of the most aggressive and treatment-resistant forms of the disease. ...

An off-the-shelf #DualAntibodyTherapy can produce deep and durable responses in #extramedullary #MultipleMyeloma, one of the most aggressive and treatment-resistant forms of the disease.
#AntibodyTherapy #TreatmentResistance #MultipleMyelomaTreatment

Interesting study showing how genetic variation can limit antibody therapies, led by the DBM team (Lepore & Jeker) with computational structural analysis from @torstenschwede.bsky.social @biozentrum.unibas.ch

www.biozentrum.unibas.ch/news/detail/...

#PrecisionMedicine #Genetics #AntibodyTherapy

New Antibody Halts One of the Deadliest Breast Cancers Scientists have uncovered a powerful new antibody that disrupts a key protein helping triple-negative breast cancer survive and evade immunity. Triple-negative breast cancer (TNBC) is considered one of...

New Antibody Halts One of the Deadliest Breast Cancers #Science #HealthandMedicine #Oncology #BreastCancer #AntibodyTherapy #OncologyResearch

New antibody therapy reawakens immune system to fight pancreatic cancer – BioNews Central Study reveals how pancreatic cancer tumors evade immunity using a sugar disguise, and how a new antibody therapy restores immunity in mice. ...

Study reveals how #PancreaticCancer #tumors evade #immunity using a sugar disguise, and how a new #AntibodyTherapy restores immunity in mice.
#ImmuneEvasion #TherapyResistance

Antibody Drug Discovery Market Size, Growth Statistics 2035 Antibody Drug Discovery Market Industry is expected to grow from 48.97(USD Billion) in 2024 to 89.6(USD Billion) by 2035. The Antibody Drug Discovery Market CAGR (growth rate) is expected to be around...

The Antibody Drug Discovery Market drives innovation in targeted therapeutics. 🧫💉 www.marketresearchfuture.com/reports/anti... #Biopharma #DrugDiscovery #AntibodyTherapy

Single Domain Antibody Platform Market Size, Trends 2032 | MRFR Single Domain Antibody Platform Market 2025, Industry to reach USD 4.2 Billion, at 8.24% CAGR by growing size, share, top company analysis, segments research, trends and forecast report 2032.

🧪 Mini antibodies, massive potential! 🧬 Transforming immunotherapy & diagnostics with next-gen antibody platforms.
#Biologics #AntibodyTherapy #PharmaInnovation

www.marketresearchfuture.com/reports/sing...

HCA Healthcare launches bispecific antibody therapy The treatment for stage small cell lung cancer is not available on the NHS, and this is the first time a lung cancer patient has been treated with this therapy at a HCA Healthcare UK hospital.

US-owned private hospital operator HCA Healthcare has introduced bispecific antibody therapy for patients with extensive-stage small-cell lung cancer.

healthcaretoday.com/article/hca-...

#healthcare #lungcancer #antibodytherapy #patientsafety

GPCR Antagonism via Antibody-Mediated Rewiring of Receptor Trafficking and Degradation
Adachi, A., Adelman, K. et al.
Paper
Details
#GPCRMechanisms #AntibodyTherapy #ReceptorTargeting

4TEEN4 begins trial of antibody therapy for cardiogenic shock - PharmaTimes First patient dosed in phase 1b/2a study of procizumab

#4TEEN4 #4TEEN4Pharmaceuticals #antibodytherapy #cardiogenicshock #phase1b/2astudy #procizumab #monoclonalantibody #PROCARD1trial #circulatingdipeptidylpeptidase3 #cDPP3 #cardiacdepressionfactor #shock #cDPP3inhibitor #angiotensinII #PROCARD1study
pharmatimes.com/news/4teen4-...

Scientists Unveil New Antibody That Supercharges Immune Attack on Tumors The antibody PLT012 targets the fat transporter CD36 to restore immune responses in tumors, offering a new and promising approach to treating immunotherapy-resistant cancers. A new study from Ludwig Cancer...

Scientists Unveil New Antibody That Supercharges Immune Attack on Tumors #Science #HealthandMedicine #Oncology #Immunotherapy #CancerResearch #AntibodyTherapy

The Antibody From a Survivor That Outsmarts Ebola – With a Tiny Dose A team of scientists has uncovered the remarkable potential of a human antibody, mAb 3A6, in fighting Ebola virus infections. Sourced from a survivor of the devastating 2014–2016 outbreak, this antibody...

The Antibody From a Survivor That Outsmarts Ebola – With a Tiny Dose #Science #HealthandMedicine #InfectiousDiseases #EbolaResearch #AntibodyTherapy #PublicHealth

CAR T cells based on fully human T cell receptor–mimetic antibodies exhibit potent antitumor activity in vivo Development of fully human T cell receptor–mimetic antibodies enabled the generation of CAR T therapies against intracellular tumor-specific antigens.

This approach could pave the way for next-generation immunotherapies, expanding the potential of antibody-based treatments! 🧬💡

www.science.org/doi/10.1126/...

#Immunotherapy #TCRm #AntibodyTherapy #CAR-T #CancerResearch #Biotech #PrecisionMedicine

Cancer therapy with antibodies - Nature Reviews Cancer In this Review, Paul et al. provide an overview of therapeutic antibodies as an important modality in cancer therapy today. They summarize the different approaches used by antibodies to target cancer cells including those of immune checkpoint inhibitors, bispecific antibodies...

🥳 Our 2nd most downloaded article in 2024:

Cancer therapy with antibodies by Paul, Gabelli, Ho, van Elsas et al.

https://bit.ly/3EjrG

#drugdevelopment #cancertherapy #antibodytherapy

@natureportfolio.bsky.social #NRCtop10of2024

NICE endorses Neuraxpharm's ublituximab for treating MS - PharmaTimes New antibody therapy shows promise in managing condition

#NICEnews #NICErecommended #Neuraxpharm #ublituximab #BRIUMVI #MABS #MS #multiplesclerosis #MStreatment #multiplesclerosistreatment #patientoutcomes #antibodytherapy #NeuraxpharmGroup #relapsingremittingmultiplesclerosis #RRMS #MSpatients #TGTherapeutics
pharmatimes.com/news/nice-en...

#BiotechInnovation
#ImmuneResponse
#LymphomaTreatment
#ClinicalTrials
#CellEngineering
#CytokineTherapy
#NextGenMedicine
#PersonalizedMedicine
#RegenerativeMedicine
#CellAndGeneTherapy
#TumorMicroenvironment
#CancerCare
#TCellActivation
#AntibodyTherapy
#ResearchForACure

Fibrin fuels thromboinflammation and brain damage in COVID-19 Researchers reveal fibrin's critical role in COVID-19 by driving thromboinflammation and neuropathology, and highlight a potential antibody therapy to mitigate these effects.

Fibrin fuels thromboinflammation and brain damage in COVID-19 🔬🧠💉 www.news-medical.net/news/2024082... #COVID19 #Fibrin #Thromboinflammation #Neuropathology #AntibodyTherapy #LongCOVID #ImmuneResponse #Brain #Health #ViralResearch @natureportfolio.bsky.social

Novel bispecific antibodies show promise against evolving SARS-CoV-2 variants Researchers developed bispecific antibodies targeting both the N-terminal and receptor binding domains of SARS-CoV-2, demonstrating significant neutralization across various Omicron variants, suggesti...

Novel bispecific antibodies show promise against evolving SARS-CoV-2 variants 🦠🧬💉 www.news-medical.net/news/2024050... #COVID19Research #Bispecific #Antibodies #Omicron #Variants #Vaccine #AntibodyTherapy #Pandemic #ViralNeutralization #SARSCoV2 @biorxivpreprint.bsky.social